EUVIMEDEUVIMED entdecken
Crossref

In Silico Study of Pertussis Toxin S1 for Recombinant Pertussis Vaccine Development in Indonesia

Ricky Rinaldi, Umi Baroroh, Fauzian Giansyah Rohmatulloh, Yusuf Sofyan Efendi, Mia Tria Novianti, Ade Rizqy Ridwan Firdaus, Toto Subroto, Muhammad Yusuf

Indonesian Journal of Computational Biology (IJCB) · 2022

DOI: 10.24198/ijcb.v1i1.40911 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indonesian Journal of Computational Biology (IJCB), 2022. Verfasst von Ricky Rinaldi und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pertussis or whooping cough is a disease caused by Bordetella pertussis bacteria, and the spread disease can be controlled by vaccination. Currently, some pertussis toxoids are prepared by chemical modification, which makes it possible to change the immunospecificity. To avoid altering the structure of toxoids, genetic modification is considered more harmless than chemical modification. A mutant of R9K/E129G is known to have lower toxicity and can be used as a component of the pertussis vaccine. However, the reason behind the low toxicity of this toxoid at the molecular level remains unclear. Hence, this study aimed to investigate the molecular mechanism behind the low toxicity of R9K/E129G using molecular dynamics simulation. The structure of the mutant was built using the homology modeling approach, and the behavior of wild-type and mutant toxoid were studied by molecular dynamics simulation for 300 ns. The changes in the structure in all systems were calculated by POVME, which was further investigated by molecular docking with NAD+ as the substrate. The results showed that the active site of the wild type was opened in the reducing environment while the mutant remained closed, which hindered the binding of NAD+. In conclusion, the dual mutation of R9K/E129G reduces pertussis toxoid's toxicity by preventing the catalytic site's opening. Therefore, this natural mutant can be further optimized in the development of a safer vaccine for pertussis. Keywords: Pertussis toxin, R9K/E129G mutant, molecular dynamics simulation, NAD+ binding site, vaccine.

Zitieren

APA

Rinaldi, R., Baroroh, U., Rohmatulloh, F. G., Efendi, Y. S., Novianti, M. T., Firdaus, A. R. R., Subroto, T., & Yusuf, M. (2022). In Silico Study of Pertussis Toxin S1 for Recombinant Pertussis Vaccine Development in Indonesia. Indonesian Journal of Computational Biology (IJCB). https://doi.org/10.24198/ijcb.v1i1.40911

Vancouver

Rinaldi R, Baroroh U, Rohmatulloh FG, Efendi YS, Novianti MT, Firdaus ARR, et al. In Silico Study of Pertussis Toxin S1 for Recombinant Pertussis Vaccine Development in Indonesia. Indonesian Journal of Computational Biology (IJCB). 2022. doi:10.24198/ijcb.v1i1.40911

BibTeX
@article{Rinaldi2022,
  author = {Rinaldi, Ricky and Baroroh, Umi and Rohmatulloh, Fauzian Giansyah and Efendi, Yusuf Sofyan and Novianti, Mia Tria and Firdaus, Ade Rizqy Ridwan and Subroto, Toto and Yusuf, Muhammad},
  title = {In Silico Study of Pertussis Toxin S1 for Recombinant Pertussis Vaccine Development in Indonesia},
  journal = {Indonesian Journal of Computational Biology (IJCB)},
  year = {2022},
  doi = {10.24198/ijcb.v1i1.40911}
}
Kostenlos starten →